Smith, B.L., Tang, R., Rai, U., Plichta, J.K., Colwell, A.S., Gadd, M.A., Specht, M.C., Austen, W.G. and Coopey, S.B. (2017) Oncologic Safety of Nipple-Sparing Mastectomy in Women with Breast Cancer. Journal of the American College of Surgeons, 225, 361-365.
https://doi.org/10.1016/j.jamcollsurg.2017.06.013

has been cited by the following article:

• TITLE: The Place of Nipple-Sparing Mastectomy in the Treatment of Breast Cancer: Review of the Literature

  AUTHORS: Abdallah El Farouqi, Anas Boumzough

  KEYWORDS: Nipple-Sparing Mastectomy, Breast Cancer, Local Recurrence, Necrosis of the Nipple, Global Complications

  JOURNAL NAME: Open Journal of Obstetrics and Gynecology, Vol.11 No.12, December 23, 2021

  ABSTRACT: Introduction: Mastectomy with conservation of the nipple-areola complex (NAC) in breast cancer care has been controversial with regards to the oncological safety of this procedure and the risk of complications including NAC necrosis. Aim: The objective of this study is to assess, through a literature review, the safety and reliability of a conservative NAC mastectomy in breast cancer treatment, paying attention to the rate of local recurrence and complications. Methods: A review of the literature was conducted from PubMed data, and articles published between January 2007 and December 2017, using the terms “nipple-sparing mastectomy”, “breast cancer”, “local recurrence”, “necrosis of the nipple”, “global complications”. The articles were analyzed with regards to the following parameters of evaluation: local recurrence, recurrence rate at NAC level, global complication rates and nipple necrosis rates. Results: In the 36 studies we selected, the average rate of local recurrence was 3.23%. The average rate of recurrence at the NAC was 0.81%. The average rate of complications was 20%. The average rate of necrosis of the NAC was 5.9%. The main factors of these recurrences were the tumor size > 5 cm and tumor stage > stage II. Conclusion: Conservative mastectomy of the nipple-areola complex offers an aesthetic advantage and oncological safety in carefully selected patients with breast cancer.